ArticleDiagnostics (Basel, Switzerland)2022
Diagnostic and Therapeutic Pathways of Intramuscular Myxoma.
Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 13 citations in OpenAlex.
- Myxoma of the round ligament mimicking femoral hernia: a diagnostic surprise in the operating room.International journal of surgery case reports · 2026Article
- Molecular Characterization and Its Clinical Application of GNAS Variants in Intramuscular Myxoma.Cancer medicine · 2026Article
- Intramuscular Myxoma: Results from the Largest European Single-Center Study-Clinical and Pathological Findings and Syndromal Associations.Diagnostics (Basel, Switzerland) · 2026Article
- Intramuscular myxoma of the supinator muscle causing posterior interosseous nerve palsy: a case report and review of literature.Journal of surgical case reports · 2025Article
- MRI Radiomics Analysis in the Diagnostic Differentiation of Malignant Soft Tissue Myxoid Sarcomas From Benign Soft Tissue Musculoskeletal Myxomas.Journal of magnetic resonance imaging : JMRI · 2025Article
- A case report of myxoma within the right submandibular muscle and a literature review.Frontiers in surgery · 2025Article
- Mazabraud's syndrome in female patients: Two case reports.World journal of orthopedics · 2024Article
- The Clinical, Radiological, and Histopathological Characteristics of Intramuscular Myxoma: A Case Report.Cureus · 2024Article
- Fibrous dysplasia: A tale of two syndromes.SA journal of radiology · 2024Article
- Understanding a mass in the paraspinal region: an anatomical approach.Insights into imaging · 2023Review
- Rare forearm intramuscular myxoma: A case report.Clinical case reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intramuscular myxomas (IMMs) are benign tumors. Evidence regarding diagnostic and therapeutic pathways is rare, and guidelines do not exist due to their low incidence. The aim of this study was a retrospective analysis at a university cancer center and the interdisciplinary re-evaluation of the individual diagnostic and therapeutic procedures. Overall, 38 patients were included in the study. IMMs occurred mostly in middle-aged women. At the time of first consultation, 57.9% had few symptoms or were asymptomatic. In 92.1% of the cases, the tumor was localized in the extremities. The lower extremity was affected in 73.7%. The average size of IMMs was 5.0 cm. The proximally located tumors in the gluteus, thighs, and upper arms were significantly larger (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.